Insights

UCL Technology Fund and Orchard Therapeutics: from idea to Nasdaq IPO and beyond

Dr Simon Goldman, interviews CEO of Orchard Therapeutics, Professor Bobby Gaspar.

Related Content

We make UCL’s research physical and life sciences ideas happen.